| 1. | Optimized measurement of calcineurin phosphatase activity in brain extracts
活性测定方法的优化 |
| 2. | Inositol 1 , 4 , 5 - trisphosphate receptor involved in the activation of calcineurin signaling pathway in myocardium
三磷酸肌醇受体参与心肌钙调神经磷酸酶信号通路的激活 |
| 3. | Study of the alteration of calcineurin activity regulated by cyclosporine a in vital organs of 1k1c renal hypertensive rats
对肾性高血压大鼠重要脏器钙调神经磷酸酶活性的调控 |
| 4. | Calcineurin inhibitors ( cyclosporine or tacrolimus ) comprised the immunosuppressive therapy in 49 pregnancies ( 94 . 2 % )
49次妊娠（ 94 . 2 % ）是在采用包含钙调神经抑制剂（环孢素或他克莫司）的免疫抑制方案。 |
| 5. | This article reviews published experience to date with steroid and calcineurin minimization in pediatric renal transplantation and discusses the risks and benefits of these approaches
这篇文章综述了迄今为止已发表的在儿童肾移植中应用类固醇和钙调磷酸酶最小化的经验，并讨论了这些治疗方法的风险和益处。 |
| 6. | Abstract ： the greatest benefit of immunosuppression minimization for children may lie in improving patient morbidity , by the elimination of the inherent side effects of steroid and calcineurin inhibitors ( cni )
摘要：儿童免疫抑制最小化的最大益处就在于，通过消除类固醇和钙调磷酸酶（ cni ）的固有副作用来改善患者的死亡率。 |
| 7. | Randomized , prospective studies of steroid and calcineurin inhibitor minimization and / or avoidance are warranted to clearly confirm the short and long - term safety and efficacy of alternative immunosuppression combinations
类固醇与钙调磷酸酶抑制剂的最小化和/或避免应用的前瞻性随机研究，能够确保明确替代免疫抑制制剂疗法的短期和长期的安全性与有效性。 |
| 8. | We report our experience , the largest to date , of sirolimus - induced pneumonitis following lt . between 1999 and 2006 , 186 lier transplant patients receied sirolimus - based immunosuppression , after initial therapy with calcineurin inhibitors ( cnis )
我们报道了至今为止在肝移植术后西罗莫司诱发性肺炎方面病例数最多的经验. 1999年至2006年, 186例患者开始给予钙调抑制剂,后接受基于西罗莫司的免疫抑制治疗 |
| 9. | Calcineurin inhibitor minimization and addition of mycophenolate mofetil ( mmf ) or sirolimus have shown variable improvements in renal function , though suboptimal efficacy and safety with the currently proposed regimes have limited their application
钙调磷酸酶抑制剂最小化以及附加麦考酚酸莫酯( mmf )或西罗莫司，已经展现出不定的改善肾功能的作用，虽然欠佳的疗效和安全性以及当前提出的管理体制限制了它们的应用。 |
| 10. | Recent findings : primary interest in antibody induction now falls into four major categories : steroid avoidance ; calcineurin inhibitor reduction as a renal sparing protocol ; minimal immunosuppression protocols ( tolerance ) ; and limiting hepatitis c recurrence
最近的发现：抗体诱导的主要益处现在可以分成四类：避免类固醇的使用；减少钙调磷酸酶抑制剂的剂量，作为一种肾保护性方案；获得最低限度的免疫抑制方案（耐受） ；限制丙型肝炎复发。 |
